Objectives: To assess the effect of triclosan on fatty acid synthesis and to relate the inhibition of enoyl reductase to bacterial viability.
Introduction
Since the discovery of the inhibition of enoyl reductase (FabI) by triclosan in Escherichia coli, 1 this bisphenol has been found to inhibit the enzyme in other microorganisms such as Pseudomonas aeruginosa 2 and Staphylococcus aureus. 3, 4 The FabI family of enoyl-ACP reductases forms non-covalent, high-affinity ternary complexes with triclosan and NAD(P) + , thus preventing the enzyme from participating in the biosynthetic pathway. 5 This inhibition is achieved by triclosan binding to the enoyl reductase active site at a site adjacent to the nicotinamide ring of the nucleoside co-factor. Triclosan's phenol ring forms a face-to-face interaction with the nicotinamide ring, allowing extensive interaction. 6 Following the identification of triclosan's inhibition of enoyl reductase, other genes coding for enoyl reductases have been identified, namely fabK in Streptococcus pneumoniae and P. aeruginosa, 7 fabL in Bacillus subtilis, 5 and InhA in Mycobacterium tuberculosis and Mycobacterium smegmatis. 8 While InhA is susceptible to triclosan, 8 both FabK and FabL are resistant. 5, 7 Such inhibition of fatty acid synthesis by triclosan was also identified in higher organisms such as Plasmodium falciparum, 9,10 the protozoan that causes malaria, and Toxoplasma gondii.
11 Both these organisms, as members of the apicomplexan, contain a type II fatty acid synthase. 12 More recently, triclosan was reported to inhibit a type I fatty acid synthase (a multifunctional form characteristic of mammals) in breast cancer cells, 13 although generally such enzymes are thought to be insensitive. Biocides have usually been described to possess multiple target sites in microbial cells, the inhibition or destruction of which results in bacteriostatic and/or bactericidal effects. Triclosan is particularly unique, as at low concentrations the bisphenol has been considered to have a single target site in several 14 This has led to controversies as to whether such a selective mode of action of triclosan could lead to the emergence of bacteria resistant to the bisphenol and other antimicrobials by modification of the enoyl reductase enzyme.
The aim of this investigation was to assess the effect of triclosan on fatty acid synthesis in triclosan-susceptible, -resistant and -non-susceptible bacterial strains, and to attempt to relate the inhibition of enoyl reductase to bacterial viability.
Materials and methods

Test organisms
The triclosan-susceptible E. coli ATCC 8739 (MIC< 0.1 mg/L; subsequently referred to as E. coli TM0) and its tolerant counterpart (MIC > 1000 mg/L; subsequently referred to as E. coli TM3, courtesy of Dr G. McDonnell, Steris Corporation, Cleveland, OH, USA), and the triclosan-non-susceptible P. aeruginosa ATCC 15442 15 were used in this study. E. coli TM3 was obtained by serially subculturing E. coli All strains were grown at 378C in M9 minimal media (Sigma, Poole, UK) prepared with added MgSO 4 (Fisher Chemicals, Loughborough, UK) and D-glucose (BDH Chemicals, Poole, UK). Stock cultures were kept in tryptone soya agar (TSA; Oxoid, Basingstoke, UK) at 48C and were renewed every fortnight. Two sequential subcultures in M9 were carried out prior to any experiment.
Inhibition of fatty acid synthesis
Five millilitres of an overnight culture (containing 1 Â 10 8 to 5 Â 10 8 cfu/mL) in M9 were added to 5 mL of fresh pre-warmed media at 378C containing 20 mL of [1- 14 C]acetate (specific activity of 2.15 GBq/mmol; Amersham International, Amersham, UK) and different concentrations of triclosan (Ciba Specialty Chemicals, Grenzach-Wyhlen, Germany). The bisphenol was prepared using dimethyl sulphoxide (DMSO; Sigma) as a co-solvent to a maximum of 1% (v/v) and equivalent amounts of DMSO were added to all cultures to guard against non-specific effects. After 15 s, and every 25 min thereafter, a 1 mL sample was taken and centrifuged at 6000 rpm (3000 g) for 3 min (MSE Microcentaur, Sanyo, Japan). The supernatant was discarded and the pellet resuspended in 1 mL of distilled water. Ten microlitres of the suspension was used for scintillation counting measured in a KLB Wallac, 1209 Rackbeta liquid scintillation counter (Wallac Oy, Finland) using Optifluor (Perkin Elmer, Boston, MA, USA) as scintillation cocktail. Quench correction was made by the external standard channels ratio method as indicated in the manufacturer's manual.
Prior to the investigation of the effect of triclosan on fatty acid synthesis, the uptake of acetate into these bacteria was investigated. Samples were prepared as described above, in the absence of triclosan. After 15 s and every 25 min thereafter, samples were taken and spun down as described above. An aliquot (0.5 mL) of the supernatant was retained for scintillation counting and the cell pellet was resuspended in 1 mL of distilled water.
Lipid extraction
Lipid extraction was carried out using a method first described by Garbus and colleagues. 16, 17 Cell pellets were suspended in 1 mL water and 3.75 mL chloroform-methanol (1:2 v/v; both obtained from Fisher Chemicals) was added. After thorough mixing, the solution was left for 15 min at room temperature (258C), after which 1.25 mL chloroform and 1.25 mL Garbus buffer (2 M potassium chloride in 0.5 M phosphate buffer at pH 7.4; Fisher Chemicals) were added. After thorough mixing, the suspensions were left to stand at room temperature for 15 min and then centrifuged at 1500 rpm (1000 g) for 10 min (Baird & Tatlock Auto Bench centrifuge with fixed angle rotor). The procedure provided a very efficient extraction of membrane lipids including very polar materials. 16 The lower phase (containing lipids) was removed and dried under a stream of oxygenfree nitrogen gas (BOC Gases, Guildford, UK). This portion, which comprised the total lipid extract, was finally resuspended in 1 mL of chloroform. Aliquots were then taken, the chloroform evaporated and radioactivity determined by scintillation counting in Optifluor.
Bactericidal effect of triclosan
In order to assess the relationship between fatty acid synthesis and bacterial growth, cultures were prepared as described previously without the radiolabelled acetate but with the same triclosan concentrations. After 15 s and every 30 min thereafter, samples were taken and neutralized using 9 mL of the neutralizer (lecithin 3 g/L; polysorbate 80 30 g/L, L-histidine 1 g/L, sodium thiosulphate 5 g/L in tryptone soya broth; CEN 1499; 1997). 18 The potential bacterial toxicity and the ability of the neutralizer to quench the activity of triclosan was tested prior to this investigation and found to be satisfactory (data not shown). 19 After a minimum of 5 min contact with the neutralizer, samples were serially diluted in phosphate buffer solution (Sigma) and spotted in triplicate onto TSA as described elsewhere. 18 After an overnight incubation at 378C, spots that contained between three and 30 colonies were counted and the bacterial concentration was expressed as cfu/mL.
Results
Uptake of acetate onto the cell
Total uptake of radioactive acetate into the three bacterial strains is shown in Figure 1 . In each case uptake was initially rapid and then plateaued. The final values of incorporated acetate against the initial concentration of acetate were about 32.76%, 32.65% and 23.74% for E. coli TM0, TM3 and P. aeruginosa, respectively. All bacteria had a high value at the initial time point. Nominally this was 15 s but, because cells had to be centrifuged down from the medium the actual time was nearer 3.5 min. Such initial values (at time 15 s) indicated an early rapid flux of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]acetate, particularly in the triclosan-susceptible E. coli TM0 ( Figure  1 ). Radiolabelled acetate was incorporated at a slower rate in the triclosan-resistant mutant TM3 over the first 60 min (Figure 1 ).
Triclosan inhibition of fatty acid biosynthesis and its effect on cell viability
The range of triclosan concentrations investigated here depended upon the bacterial cells. For the triclosan-susceptible E. coli TM0, concentrations of 0, 0.1 and 1 mg/L were investigated, whereas concentrations of 0, 20 and 40 mg/L were used for the other two strains.
Figures 2-4 present viable counts and [1-
14
C]acetate incorporation into lipid depending upon triclosan concentration for the three bacterial strains studied. It was clear that triclosan inhibited the incorporation of radioactive acetate into lipid in a concentration-dependent manner in all the microorganisms tested.
In the parent strain E. coli TM0 (Figure 2 ), the incorporation of radioactivity into total lipids in the absence of triclosan rose steadily throughout the period of the experiment. At the same time, the number of bacteria increased from 4.91 Â 10 4 to 1.14 Â 10 5 cfu/mL. Triclosan at 0.1 mg/L prevented growth and reduced radiolabel incorporation into lipids by $ 70% within a 75 min period. After 75 min, unlike cultures in the absence of triclosan, there was no further labelling of lipids. Triclosan 1 mg/L both prevented lipid labelling and inhibited bacterial growth (Figure 2) .
The triclosan-resistant E. coli TM3 showed a similar population growth pattern (Figure 3) to the parent strain. Incorporation of radioactivity into lipids was also broadly comparable. Much higher concentrations of triclosan were used and growth was prevented at both 20 and 40 mg/L. At 20 mg/L triclosan, lipid labelling was reduced by $ 55% and, in a similar fashion to the intermediate concentration used from E. coli TM0 (Figure 2 ) after 100 min labelling appeared to plateau. The highest concentration of triclosan (40 mg/L) effectively prevented lipid labelling and bacterial growth.
For P. aeruginosa, high concentrations of triclosan were also used. Although the cultures without triclosan showed significant growth and continuous incorporation of radioactivity into lipid (Figure 4) , both 20 and 40 mg/L prevented bacterial growth.
At 20 mg/L triclosan, lipid labelling was poor but then increased between 50 and 75 min, after which it plateaued. This period was just before cell division appeared to take place in control cultures. Even so, at 75 min lipid labelling of 20 mg/L triclosantreated cultures was half of controls. Triclosan at 40 mg/L was a strong inhibitor of both lipid labelling in, and growth of, P. aeruginosa.
Discussion
Triclosan has been shown previously to inhibit fatty acid synthesis. 1, 3, 9 This was confirmed in the present study by the inhibition of incorporation of radioactivity from [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]acetate into lipid.
In all of the bacterial strains tested it was possible to inhibit lipid labelling completely. However, much higher concentrations of triclosan were needed to produce such inhibition in the resistant E. coli strain and in the inherently non-susceptible P. aeruginosa. At intermediate concentrations of triclosan it was possible to achieve some lipid labelling, but in these cases there was no increase in bacterial population as measured by viable cell numbers. This suggests that, if inhibition of fatty acid synthesis is the primary site of action for triclosan, its complete inhibition does not necessarily correlate with a bactericidal effect, but rather with a bacteriostatic one. Triclosan is likely to have another important site(s) of action that causes lethality independent of the effect on fatty acid biosynthesis. Likewise, it was notable that when complete inhibition of lipid labelling was achieved following challenges with higher concentrations of the bisphenol, viable counts were not significantly reduced over the experimental period. Thus, complete inhibition of fatty acid biosynthesis, via enoyl reductase, does not immediately produce lethality. It is clear that at these concentrations, triclosan acts as a bacteriostatic agent. These experiments were conducted over a 150 min period only, but one may speculate that if lipid synthesis was prevented over a long period of time then membranes could be neither made nor renewed, and the microorganisms would eventually die.
Our data show that, provided the concentrations of triclosan are appropriate, it is possible to produce similar effects on viable counts and fatty acid synthesis in all bacteria whether they are susceptible, have acquired resistance or are inherently nonsusceptible. As others have noted, 7, 20 resistance to high concentrations of triclosan could be associated with the properties of enoyl reductase, but also, and more probably, by a reduction in the effective intracellular concentration of triclosan. Our results clearly showed that the bacteriostatic activity of triclosan is associated with an inhibition of membrane biogenesis. However, the inhibition of fatty acid synthesis does not account for any short-term bactericidal activity. These results might question the use of enoyl acyl reductase as a target for non-biocidal antimicrobial design.
